Nooshi?!! Är det du? Varför pratar du engelska och varför har du bytt ditt namn? Hursomhelst jag vet att du bara låtsas att inte veta vart Gävle ligger för jag såg dig på grand hotel för två månader sen men kanske studera lite ändå för det var ganska pinsamt

I thought you were Mia Khalifa

We are incredibly lucky 🍀

Excited to have you on the team 🦾

So excited to have you here 🦾🧬

Congrats @Chandanananana 👏🏽 big win for @medra_ai 🙌🏾

New chapter! I’m now at @medra_ai (BD/Partnerships)👋🏾 A few weeks back, I wrapped up an incredible chapter @RecursionPharma founding/building @AltitudeLab. Endless gratitude to our team, Altitude is in perfect hands with @sharmaofslc taking the reins. I'm absolutely stoked to create the data engine for a new era of continuous science. This team's intensity is unmatched; Medra is delivering on huge gaps in AI x bio and physical AI. Honored to work on the next bold mission with @michellearning and the Medra team 💥

⏩ Momentum is building across the TechBio ecosystem. Annalee Armstrong’s recent story in @biospace captures the momentum happening across biotech – and across our thriving local Salt Lake City biotech hub. She toured Recursion-supported incubator @AltitudeLab and visited Recursion headquarters. There, she writes: “I sat in on an all-hands meeting where staff got to hear about the true impacts on a family of the incredibly difficult disease called familial adenomatous polyposis. The inherited disorder causes noncancerous polyps to grow in the colon and rectum as early as the teenage years. While patients can live with the disorder, they often face early cancers and immense, life-altering complications.” The experience was a reminder, she wrote, that “after a year of keeping its head down and riding out the bumps, biotech is doing what it’s best at again. Innovating. Making things better.” We couldn’t agree more. 👉 Read the story: biospace.com/drug-developmen…

A @UUtah spinout, CaLycia develops macrophage-engineered cell therapies that home into solid tumors like Glioblastoma to unlock a broader immune response. 🧬🔬 Welcome to the cohort! #AltitudeLab #Biotech #Immunology #CaLycia #CellTherapy

For the founder with #Labubu taste but bootstrapped budget: the #startup resources to help you advance.⬇️ 💍@Cartier Women's Initiative cartierwomensinitiative.com/… 🏆@Accenture Innovation Challenge ucsc.co/3Tc3EI4 🌱@AltitudeLab Pre-Seed Venture Fund ir.recursion.com/news-releas…

Ecosystem Excellence Award - ty for the key feature @AltitudeLab @BioHiveUtah

Each year, @UtahBusiness celebrates professionals who have led their organizations w/ courage & have made it their mission to change the way we do business in Utah. Congrats to Chandana Haque of @AltitudeLab, who is included in this year’s list! 🔗More: ow.ly/Uv3W50VqRVh

We care deeply about our mission – decoding biology to radically improve lives – and every step we take to achieve that mission. As our 2025 Corporate Environmental, Social and Governance (ESG) Report demonstrates, accelerating the industrialization of drug discovery at Recursion is also about advancing principles that we care deeply about as a company. They include: 🔹 A More Sustainable Approach: ▫️ We completed a GHG emissions reduction roadmap and calculated Scope 3 (indirect) emissions for the first time. ▫️ We continued investing in renewable energy credits (RECs) to offset 100% of our energy use at our Salt Lake City headquarters. 🔹 Supporting Patients: ▫️ Recursion supports patient communities through partnerships with @AmericanCancer, @ChildrensTumor, @RareDiseases, Alliance to Cure and Peggy Lillis Foundation, among many others. ▫️ We ensure a geographically, socio-economically, and ethnically diverse population in clinical trials to give us confidence that our results are generalizable to a representative patient population. 🔹 Building an Inclusive TechBio Community: ▫️ Our Utah-based health care accelerator @AltitudeLab , has enrolled 31 startups in its 24-month program to date. 9 of these startups have graduated and are scaling their Seed- and Series A-funded ventures in Salt Lake City. ▫️ In 2024, Altitude startups secured over $29 million in seed and Series A funding, accounting for 41% of all early stage healthcare financings in Utah, based on available data. 🔹 Commitment to Open Science: We released publicly available datasets and models like: ▫️ RxRx3-core, a streamlined, 18GB dataset of microscopy images. rxrx.ai/datasets; ▫️ OpenPhenom-S/16, a ready-to-use model that outperforms traditional microscopy analysis techniques rxrx.ai/phenom; ▫️ SAFE-GPT, a powerful AI model that can design new molecules. github.com/datamol-io/safe 🔹 A “One Recursion” Culture ▫️ In 2024, we published Decoding Recursion – an immersive book that serves as both a reflection of our journey and a guide to our future. recursion.com/recursion-deco… ▫️ We launched a Returnship Program, providing a pathway for individuals to return to the industry after a career break of two or more years. ▫️ Our pay equity analysis found no material systemic pay differences between genders. ▫️ We launched Recursion University (RXU) in February 2024, an internal learning platform designed to connect employees with the core elements of our culture, skills, and expertise. 👉 Read more: recursion.com/esg

Check out my conversation with @Chandanananana about the recently launched pressed fund @AltitudeLab cofounded (and cofunded) by @RecursionChris @RecursionPharma . Chandana talked about how the fund will invest in startups affected by SBIR funding challenges.

wewillcure.com/insights/inve… As thousands of healthcare startups are caught in limbo by @NIH funding cuts, one company is offering a potential lifeline: @AltitudeLab , a biotech accelerator started by Recursion, has created a pre-seed venture fund targeting startups with promising science but no federal dollars. Read more

Recursion was thrilled to be part of the recent @BioHiveUtah Live event -- celebrating the innovators and business leaders who are working to elevate Utah's healthcare and life sciences industry. 🌟 Special congratulations to: 🏆 @KikiMatsumoto, Recursion's Communications and Culture Fellow, who was named Storyteller of the Year. Katherine is passionate about the intersection of culture, communication, and technology, and is known for her ability to develop innovative strategies that foster a collaborative and inclusive workplace. 🏆 @AltitudeLab, Recursion's healthcare accelerator in Utah led by executive director @Chandanananana, which supports diverse life science entrepreneurs in Utah by providing fully equipped laboratories, access to investors, business operations education, and a collaborative founder community. BioHiveLive.com

Yesterday's Demo Day at @AltitudeLab showcased the achievements of 19 resident startups spanning therapeutic, diagnostic, biopharma services, and digital health all located and operating in Utah. ▪️ Run by the Recursion Foundation, Altitude Lab is building a new, representative generation of founders to seed the next cycle of health care innovation in @BioHiveUtah. ▪️ Resident startup teams included: Bonneville Bio, who are developing novel cancer therapeutics; Anziva Pharmaceuticals, who are innovating drug formulations; Freyya, who are developing the first wearable real-time biofeedback device for pelvic floor care; and Intactis Bio, who are engineering tissues to revolutionize biocomputation and regenerative medicine. ▪️ @carmen_kivisild – founder of Elnora AI and the first winner of the Chris and Summer Gibson Foundation Fellowship – was also featured in a Fireside Chat with Altitude’s executive director @Chandanananana Haque. ▪️ And Chandana announced a new pre-seed venture fund – the Altitude Lab Fund – to support early-stage SBIR-reviewed startups impacted by federal grant freezes with up to $250,000 in capital, lab space, and mentorship. 👉 Details on Demo Day: altitudelab.org/demo-day

Turns out there's a lot of interest in finding solutions. Check out coverage of @RecursionPharma's new pre-seed @AltitudeLab Fund, designed to help bridge the funding gap from recent federal grant freezes in: ▪️ @Forbes: forbes.com/sites/innovationr… ▪️ @FierceBiotech: fiercebiotech.com/biotech/al… ▪️ @MMMnews: mmm-online.com/news/recursio… ▪️ @medcitynews: medcitynews.com/2025/02/recu… ▪️ @BioPharmaDive: biopharmadive.com/news/recur… ▪️ @BiopharmaTrend: biopharmatrend.com/post/1140…

Altitude Lab Introduces Pre-seed Venture Fund, Supported by Recursion CEO Chris Gibson, Aiding SBIR-Recognized Biotech’s Facing Funding Challenges in Salt Lake City Altitude Lab, a biotechnology accelerator established by @RecursionPharma (NASDAQ: $RXRX) has unveiled its pre-seed venture fund designed to assist early-stage biotech startups affected by recent changes in federal funding policies. This initiative, in collaboration with Altitude Lab, aims to offer essential financial resources, laboratory facilities, and mentorship to promising companies that have undergone Small Business Innovation Research (SBIR) review, further enhancing Salt Lake City's status as a prominent biotechnology center. With about $4.5 billion allocated annually for SBIR and Small Business Technology Transfer (STTR) programs, federal grants have historically been vital for fostering innovation within the biotech sector. However, recent policy alterations have left approximately 1,500 health-focused startups uncertain about their future prospects. This situation threatens significant progress in medical advancements, drug development, and diagnostics that not only improve patient outcomes but also bolster America's position as a leader in health innovation. The Altitude Lab Fund is strategically positioned to address this challenge while promoting the growth of the burgeoning life sciences ecosystem in Salt Lake City by providing both capital and necessary infrastructure to high-potential startups currently at risk. FULL ARTICLE: prismmarketview.com/altitude… #StocksToWatch #StocksOnTheMove #StocksInNews #investors #daytrader #PRISMMediaWire #PRISMDigitalMedia #RecursionPharma #AltitudeLab